Literature DB >> 20835834

High-mobility group box 1 (HMGB1) as a master regulator of innate immunity.

Alessandra Castiglioni1, Valentina Canti, Patrizia Rovere-Querini, Angelo A Manfredi.   

Abstract

Damage-associated molecular patterns (DAMPs) comprise intracellular molecules characterized by the ability to reach the extracellular environment, where they prompt inflammation and tissue repair. The high-mobility box group 1 (HMGB1) protein is a prototypic DAMP and is highly conserved in evolution. HMGB1 is released upon cell and tissue necrosis and is actively produced by immune cells. Evidence suggests that HMGB1 acts as a key molecule of innate immunity, downstream of persistent tissue injury, orchestrating inflammation, stem cell recruitment/activation, and eventual tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835834     DOI: 10.1007/s00441-010-1033-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  46 in total

1.  Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Zeynep Alpay Savasan; Yi Xu; Youssef Hussein; Zhong Dong; Juan Pedro Kusanovic; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-09-29

2.  Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.

Authors:  Roberto Romero; Jezid Miranda; Juan P Kusanovic; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Alicia Martinez; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Majid Shaman; Kia Lannaman; Bo Hyun Yoon; Sonia S Hassan; Chong J Kim; Steven J Korzeniewski; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2015-01       Impact factor: 1.901

Review 3.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 4.  Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming.

Authors:  Matthew G Frank; Michael D Weber; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-03-24       Impact factor: 7.217

Review 5.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 6.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 7.  RAGE: a new frontier in chronic airways disease.

Authors:  Maria B Sukkar; Md Ashik Ullah; Wan Jun Gan; Peter A B Wark; Kian Fan Chung; J Margaret Hughes; Carol L Armour; Simon Phipps
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  Restoration of calcium-induced differentiation potential and tight junction formation in HaCaT keratinocytes by functional attenuation of overexpressed high mobility group box-1 protein.

Authors:  Fumika Tanaka; Minori Uda; Yuina Hirose; Yohei Hirai
Journal:  Cytotechnology       Date:  2020-01-08       Impact factor: 2.058

Review 9.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

Review 10.  Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.

Authors:  Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2013-08-28       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.